West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
415.65
-2.15 (-0.51%)
Nov 17, 2026, 10:44 AM EST - Market open

WST Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3973,0742,8932,9502,8872,832
Revenue Growth
12.55%6.25%-1.92%2.18%1.95%31.89%
Cost of Revenue
2,1201,9701,8951,8201,7511,654
Gross Profit
1,2771,104998.51,1301,1361,178
Selling, General & Admin
426.2389.7334.9354.1316356.3
Research & Development
75.674.369.168.458.552.8
Other Operating Expenses
-1.91.30.91.3-2.1-
Operating Expenses
499.9465.3404.9423.8372.4409.1
Operating Income
777638.7593.6706.2763.8768.6
Interest Expense
-8.1-0.5-3-9-7.9-8.2
Interest & Investment Income
18.317.519.6285.11
Earnings From Equity Investments
17.714.414.717.720.720.1
Currency Exchange Gain (Loss)
-6.7-8.4-10.2-9.44.11.4
EBT Excluding Unusual Items
798.2661.7614.7733.5785.8782.9
Merger & Restructuring Charges
-26.9-29.5-2.12-23.8-2.2
Gain (Loss) on Sale of Investments
-8-4.5-0.3-4.3-3.5-4.3
Gain (Loss) on Sale of Assets
55.7---11.6--
Asset Writedown
-3.4-3.7-7-5.3-2.7-4.1
Legal Settlements
---3.8--
Other Unusual Items
-8.5-8.7-5.1-2.4-55.2-3.3
Pretax Income
807.1615.3600.2715.7700.6769
Income Tax Expense
168.2121.6107.5122.3114.7107.2
Net Income
638.9493.7492.7593.4585.9661.8
Net Income to Common
638.9493.7492.7593.4585.9661.8
Net Income Growth
29.94%0.20%-16.97%1.28%-11.47%91.16%
Shares Outstanding (Basic)
717273747474
Shares Outstanding (Diluted)
727374757676
Shares Change
-1.47%-1.36%-2.13%-0.66%-0.66%0.66%
EPS (Basic)
8.956.836.757.997.888.90
EPS (Diluted)
8.906.796.697.887.738.67
EPS Growth
31.87%1.49%-15.10%1.94%-10.84%89.72%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
453.4468.9276.4414.5439.4330.6
Free Cash Flow Per Share
6.326.453.755.505.804.33
Dividend Per Share
0.8800.8500.8100.7700.7300.690
Dividend Growth
4.76%4.94%5.20%5.48%5.80%6.15%
Gross Margin
37.59%35.91%34.51%38.31%39.36%41.59%
Operating Margin
22.88%20.78%20.52%23.94%26.46%27.14%
Profit Margin
18.81%16.06%17.03%20.12%20.29%23.37%
Free Cash Flow Margin
13.35%15.25%9.55%14.05%15.22%11.68%
EBITDA
961.3810.1749843.5884.4890.9
EBITDA Margin
28.30%26.35%25.89%28.59%30.64%31.46%
D&A For EBITDA
184.3171.4155.4137.3120.6122.3
EBIT
777638.7593.6706.2763.8768.6
EBIT Margin
22.88%20.78%20.52%23.94%26.46%27.14%
Effective Tax Rate
20.84%19.76%17.91%17.09%16.37%13.94%
SEC Filings: 10-K · 10-Q